| ²é¿´: 578 | »Ø¸´: 6 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
blueangelhuiÌú³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÓÐCASºÅ£¬Ë°ïÎÒÓÃscifinder»òÕßĬ¿ËË÷Òý²éÒ»ÏÂËûµÄÎïÀí»¯Ñ§ÐÔÖÊ
|
|||
|
¸÷λ´óÉñ£¬ÇóÖúÁË¡£ ÎÒÏë²éÒ»ÏÂÒ»¸ö»¯Ñ§ÎïÖʵÄÎïÀí»¯Ñ§ÐÔÖÊ¡£ CASºÅ 274901-16-5 vildagliptin ͨ¹ýscifinder»òÕßĬ¿ËË÷Òý£¬ËÓÐ×ÊԴѽ£¿ ¸Ð¼¤²»¾¡ |
» ²ÂÄãϲ»¶
¿¼Ñе÷¼Á
ÒѾÓÐ7È˻ظ´
0856µ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏ277Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö)
ÒѾÓÐ8È˻ظ´
334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
0703»¯Ñ§/290Çóµ÷¼Á/±¾¿Æ¾Àú·á¸»/¹¤¿ÆÒ²¿É
ÒѾÓÐ6È˻ظ´
±±¿Æ281ѧ˶²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
275Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
baiyuefei
°æÖ÷ (ÎÄѧ̩¶·)
·çÑ©
- Ó¦Öú: 4642 (¸±½ÌÊÚ)
- ¹ó±ö: 46.969
- ½ð±Ò: 658106
- É¢½ð: 11616
- ºì»¨: 995
- ɳ·¢: 81
- Ìû×Ó: 69424
- ÔÚÏß: 13328.4Сʱ
- ³æºÅ: 676696
- ×¢²á: 2008-12-18
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
- ¹ÜϽ: Óлú½»Á÷
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ðľ²_ÒÀÈ»: ½ð±Ò+2, лл»ØÌû 2015-05-29 16:39:09
blueangelhui(Ðľ²_ÒÀÈ»´ú·¢): ½ð±Ò+2 2015-05-30 09:40:02
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ðľ²_ÒÀÈ»: ½ð±Ò+2, лл»ØÌû 2015-05-29 16:39:09
blueangelhui(Ðľ²_ÒÀÈ»´ú·¢): ½ð±Ò+2 2015-05-30 09:40:02
|
Ĭ¿ËË÷Òý Vildagliptin Back to search results Add to My Records Print view Monograph ID: M11447 Title: Vildagliptin CAS Registry Number: 274901-16-5 CAS Name: (2S)-1-[2-[(3-Hydroxy©\tricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile Additional Names: 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine Manufacturer Code: LAF-237; NVP-LAF237 Trademark Names: Equa (Novartis); Galvus (Novartis) Molecular Formula: C17H25N3O2 Molecular Weight: 303.41 Percent Composition: C 67.30%, H 8.31%, N 13.85%, O 10.55% Properties White solid from ethyl acetate, mp 138-140 ¡ãC; from 2-propanol, mp 148-150 ¡ãC. [¦Á] −78.3 (c = 9.73 in methanol). References Dipeptidyl peptidase-IV (DPP-IV) inhibitor. Prepn: E. Villhauer, WO 0034241; idem, US 6166063 (both 2000 to Novartis); and pharmacology: idem et al., J. Med. Chem. 46, 2774 (2003) DOI: 10.1021/jm030091l PMID: 12801240. Clinical trial in type 2 diabetes: J. E. Foley, S. Sreenan, Horm. Metab. Res. 41, 905 (2009) DOI: 10.1055/s-0029-1234042 PMID: 19705345; in combination with metformin: M. Goodman et al., ibid. 368 DOI: 10.1055/s-0028-1104604 PMID: 19221978. Review of pharmacology and clinical experience: M. Banerjee et al., Expert Opin. Pharmacother. 10, 2745-2757 (2009) DOI: 10.1517/14656560903302265 PMID: 19874253. Classifications Therapeutic Category: Antidiabetic; Others; Dipeptidyl Peptidase IV Inhibitor Keywords: Antidiabetic. |
7Â¥2015-05-28 08:28:34
fatewu
Ö÷¹ÜÇø³¤ (ÎÄ̳¾«Ó¢)
Сľ³æÀËÂþÌåÑéʦ~\(^o^)/~
-

ר¼Ò¾Ñé: +790 - Ó¦Öú: 521 (²©Ê¿)
- ¹ó±ö: 19.629
- ½ð±Ò: 19729
- É¢½ð: 169099
- ºì»¨: 648
- ɳ·¢: 2560
- Ìû×Ó: 43961
- ÔÚÏß: 6049.8Сʱ
- ³æºÅ: 3063713
- ×¢²á: 2014-03-17
- רҵ: δÀ´Ñ§
- ¹ÜϽ: »¯Ñ§»¯¹¤Çø
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ðľ²_ÒÀÈ»: ½ð±Ò+2, лл»ØÌû 2015-05-29 16:38:47
blueangelhui(Ðľ²_ÒÀÈ»´ú·¢): ½ð±Ò+3 2015-05-30 09:39:38
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ðľ²_ÒÀÈ»: ½ð±Ò+2, лл»ØÌû 2015-05-29 16:38:47
blueangelhui(Ðľ²_ÒÀÈ»´ú·¢): ½ð±Ò+3 2015-05-30 09:39:38
|
½ð±ÒÂÔÉÙÁËÄÇôһµã~ https://yunpan.cn/cwHaYCiADxEZN ·ÃÎÊÃÜÂë e524 |

2Â¥2015-05-27 14:56:15
blueangelhui
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 963.4
- Ìû×Ó: 23
- ÔÚÏß: 6.2Сʱ
- ³æºÅ: 1673898
- ×¢²á: 2012-03-07
- ÐÔ±ð: MM
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
|
ÍÛ£¬ÄãÌ«ºÃÁË¡£¡£¡£ÓÐÎÊÌâÒÔºó¿ÉÒÔÇë½ÌÄãô£¿ºÙºÙ£¬ÎÒ²»¾³£ÍæÕâ¸öСľ³æ£¬ÒÔºó½ð±Ò¶àÁËÈ«¶¼ËÍÄã¡£¡£¡£ ·Ç³£¸ÐлÄã°¡£¬ºÃ¿ªÐÄ ÌØ±ð¿ªÐÄ |
3Â¥2015-05-27 19:10:17
fatewu
Ö÷¹ÜÇø³¤ (ÎÄ̳¾«Ó¢)
Сľ³æÀËÂþÌåÑéʦ~\(^o^)/~
-

ר¼Ò¾Ñé: +790 - Ó¦Öú: 521 (²©Ê¿)
- ¹ó±ö: 19.629
- ½ð±Ò: 19729
- É¢½ð: 169099
- ºì»¨: 648
- ɳ·¢: 2560
- Ìû×Ó: 43961
- ÔÚÏß: 6049.8Сʱ
- ³æºÅ: 3063713
- ×¢²á: 2014-03-17
- רҵ: δÀ´Ñ§
- ¹ÜϽ: »¯Ñ§»¯¹¤Çø

4Â¥2015-05-27 19:12:24













»Ø¸´´ËÂ¥